Blarcamesine
BMS buys Karuna for US$ 14 billion; Astra-Ionis’ nerve damage drug bags FDA nod

BMS buys Karuna for US$ 14 billion; Astra-Ionis’ nerve damage drug bags FDA nod

This week’s Phispers is a double bill with news from last week and the first days of the New Year. Bristol Myers Squibb (...

Impressions : 2486